Garfield Alastair bought RYTM
February 14, 2025 · Form 4 insider transaction
Garfield Alastair bought 26,650 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,650
Price
$0.00
Total value
N/A
InsiderGarfield Alastair
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after26,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.; The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.